Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan; Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan; Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo, Japan.
Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
J Infect Public Health. 2023 Sep;16(9):1435-1442. doi: 10.1016/j.jiph.2023.07.014. Epub 2023 Jul 23.
Zika Virus (ZIKV) is a re-emerging, arthropod-borne flavivirus transmitted by Aedes mosquitoes (Ae. aegypti and Ae. albopictus). The coexistence of dengue virus (DENV) and ZIKV concurrently has been associated with a wide array of neurological complications, which may influence the clinical outcomes of infections. Sri Lanka witnessed a severe dengue epidemic in 2017, characterized by extraordinary and severe disease manifestations with considerable morbidity. Therefore, this study assessed the potential occurrence of ZIKV infection during DENV outbreak in Sri Lanka from 2017 to 2019, which could bear substantial implications for public health.
Five hundred ninety-five serum samples were procured from individuals suspected of dengue and admitted to Kandy National Hospital between 2017 and 2018 and the Negombo District General Hospital between 2018 and 2019. These samples underwent quantitative real-time RT-PCR (qRT-PCR) to identify the presence of the ZIKV gene, while enzyme-linked immunosorbent assay was employed to detect ZIKV-specific IgM and IgG antibodies. Focus reduction neutralization tests were subsequently conducted to confirm ZIKV infection.
Among the 595 serum samples, 6 (1.0%) tested positive for ZIKV using qRT-PCR. Anti-ZIKV IgM and IgG were identified in 18.0% and 38.6% patients. Sixty-six (11.0%) samples demonstrated the presence of anti-ZIKV IgM and IgG. Within ZIKV IgM-positive samples, 2.2% exhibited neutralizing antibodies against ZIKV. Through the implementation of qRT-PCR, ZIKV IgM detection, and neutralization testing, 2% and 3.7% cases of ZIKV infections were confirmed in the Kandy and Negombo regions, respectively.
This study is the inaugural endeavor to substantiate the existence of ZIKV infection in Sri Lanka utilizing molecular and serological analysis. The findings of this investigation imply that ZIKV was circulating throughout the 2017-2019 DENV outbreak. These results underscore the necessity for improved preparedness for future outbreaks, fortifying governmental policies on public health, and establishing effective early warning systems regarding the emergence of these viruses.
Zika 病毒(ZIKV)是一种重新出现的、通过蚊虫(埃及伊蚊和白纹伊蚊)传播的虫媒黄病毒。登革热病毒(DENV)和 ZIKV 的共同存在与广泛的神经并发症有关,这可能会影响感染的临床结果。2017 年,斯里兰卡发生了严重的登革热疫情,其特点是疾病表现异常严重,发病率相当高。因此,本研究评估了 2017 年至 2019 年期间在斯里兰卡登革热疫情期间 ZIKV 感染的潜在发生情况,这对公共卫生具有重要意义。
从 2017 年至 2018 年在康提国家医院和 2018 年至 2019 年在尼甘布区总医院因疑似登革热而住院的患者中采集了 595 份血清样本。这些样本通过实时定量 RT-PCR(qRT-PCR)检测 ZIKV 基因的存在,同时使用酶联免疫吸附试验检测 ZIKV 特异性 IgM 和 IgG 抗体。随后进行焦点减少中和试验以确认 ZIKV 感染。
在 595 份血清样本中,6 份(1.0%)通过 qRT-PCR 检测到 ZIKV 呈阳性。18.0%和 38.6%的患者检测到抗 ZIKV IgM 和 IgG。66.0%的样本显示存在抗 ZIKV IgM 和 IgG。在 ZIKV IgM 阳性样本中,有 2.2%的样本对 ZIKV 具有中和抗体。通过实施 qRT-PCR、ZIKV IgM 检测和中和试验,在康提和尼甘布地区分别确认了 2%和 3.7%的 ZIKV 感染病例。
本研究首次利用分子和血清学分析证实了 ZIKV 在斯里兰卡的存在。本研究结果表明,ZIKV 在 2017-2019 年 DENV 爆发期间一直在传播。这些结果强调了为未来的疫情做好更好准备的必要性,加强了政府关于公共卫生的政策,并建立了关于这些病毒出现的有效早期预警系统。